Literature DB >> 18509629

Improving outcome after positive interim PET in advanced Hodgkin's disease: reality vs expectation.

Panayiotis D Ziakas, Loukia S Poulou.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18509629     DOI： 10.1007/s00259-008-0840-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  12 in total

1.  FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

Authors:  Martin Hutchings; Annika Loft; Mads Hansen; Lars Møller Pedersen; Thora Buhl; Jesper Jurlander; Simon Buus; Susanne Keiding; Francesco D'Amore; Anne-Marie Boesen; Anne Kiil Berthelsen; Lena Specht
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

2.  Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome.

Authors:  Eldad J Dann; Rachel Bar-Shalom; Ada Tamir; Nissim Haim; Menachem Ben-Shachar; Irit Avivi; Tzila Zuckerman; Mark Kirschbaum; Odelia Goor; Diana Libster; Jacob M Rowe; Ron Epelbaum
Journal:  Blood       Date:  2006-10-03       Impact factor: 22.113

3.  ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.

Authors:  Paolo G Gobbi; Alessandro Levis; Teodoro Chisesi; Chiara Broglia; Umberto Vitolo; Caterina Stelitano; Vincenzo Pavone; Luigi Cavanna; Gino Santini; Francesco Merli; Marina Liberati; Luca Baldini; Giorgio Lambertenghi Deliliers; Emanuele Angelucci; Roberto Bordonaro; Massimo Federico
Journal:  J Clin Oncol       Date:  2005-09-19       Impact factor: 44.544

4.  Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990-2003.

Authors:  E Jantunen; M Itälä; T Siitonen; E Koivunen; S Leppä; E Juvonen; O Kuittinen; T Lehtinen; P Koistinen; H Nyman; T Nousiainen; L Volin; K Remes
Journal:  Eur J Haematol       Date:  2006-08       Impact factor: 2.997

5.  Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.

Authors:  Navneet S Majhail; Daniel J Weisdorf; Todd E Defor; Jeffrey S Miller; Philip B McGlave; Arne Slungaard; Mukta Arora; Norma K C Ramsay; Paul J Orchard; Margaret L MacMillan; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2006-10       Impact factor: 5.742

6.  FDG PET scan strategies and long-term outcomes after first-line therapy in Hodgkin's disease.

Authors:  Loukia S Poulou; George Karianakis; Panayiotis D Ziakas
Journal:  Eur J Radiol       Date:  2008-03-14       Impact factor: 3.528

7.  Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.

Authors:  Elias Jabbour; Chitra Hosing; Gregory Ayers; Rodolfo Nunez; Paolo Anderlini; Barbara Pro; Issa Khouri; Anas Younes; Fredrick Hagemeister; Larry Kwak; Luis Fayad
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

Review 8.  Risk, cure and complications in advanced hodgkin disease.

Authors:  Sandra J Horning
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

Review 9.  The role of FDG-PET scans in patients with lymphoma.

Authors:  Pamela Seam; Malik E Juweid; Bruce D Cheson
Journal:  Blood       Date:  2007-08-20       Impact factor: 22.113

10.  Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study.

Authors:  Andrea Gallamini; Martin Hutchings; Luigi Rigacci; Lena Specht; Francesco Merli; Mads Hansen; Caterina Patti; Annika Loft; Francesco Di Raimondo; Francesco D'Amore; Alberto Biggi; Umberto Vitolo; Caterina Stelitano; Rosario Sancetta; Livio Trentin; Stefano Luminari; Emilio Iannitto; Simonetta Viviani; Ivana Pierri; Alessandro Levis
Journal:  J Clin Oncol       Date:  2007-07-23       Impact factor: 44.544
View more
  1 in total

Review 1.  Unifying the predictive value of pretransplant FDG PET in patients with lymphoma: a review and meta-analysis of published trials.

Authors:  Loukia S Poulou; Loukas Thanos; Panayiotis D Ziakas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.